Compare ARCO & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARCO | SANA |
|---|---|---|
| Founded | 2007 | 2018 |
| Country | Uruguay | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2011 | 2021 |
| Metric | ARCO | SANA |
|---|---|---|
| Price | $8.55 | $3.94 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $8.60 | $7.83 |
| AVG Volume (30 Days) | 1.6M | ★ 2.5M |
| Earning Date | 03-11-2026 | 03-16-2026 |
| Dividend Yield | ★ 2.81% | N/A |
| EPS Growth | ★ 69.06 | N/A |
| EPS | ★ 1.16 | N/A |
| Revenue | ★ $4,555,936,000.00 | N/A |
| Revenue This Year | $6.08 | N/A |
| Revenue Next Year | $7.40 | N/A |
| P/E Ratio | $7.34 | ★ N/A |
| Revenue Growth | ★ 1.21 | N/A |
| 52 Week Low | $6.51 | $1.26 |
| 52 Week High | $8.97 | $6.55 |
| Indicator | ARCO | SANA |
|---|---|---|
| Relative Strength Index (RSI) | 67.62 | 36.71 |
| Support Level | $8.06 | $3.53 |
| Resistance Level | $8.97 | $4.69 |
| Average True Range (ATR) | 0.26 | 0.34 |
| MACD | 0.08 | -0.13 |
| Stochastic Oscillator | 76.90 | 13.77 |
Arcos Dorados Holdings Inc operates McDonald's branded restaurants in various countries and territories in Latin America and the Caribbean. The Company manages its business as distinct geographic segments and its operations are divided into three geographic divisions, as follows: Brazil, the North Latin American division, or NOLAD, which is comprised of Costa Rica, Mexico, Panama, Puerto Rico, Martinique, Guadeloupe, French Guiana and the U.S. Virgin Islands of St. Croix and St. Thomas and the South Latin American division, or SLAD, which is comprised of Argentina, Chile, Ecuador, Peru, Uruguay, Colombia, Venezuela, Trinidad and Tobago, Aruba and Curacao. Their menu includes hamburgers, McNuggets, salad, sandwiches, French fries, and others.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.